Written Informed Consent Act
Sponsored By: Senator Sheehy, Tim [R-MT]
Introduced
Summary
Expands VA informed consent requirements to five medication categories for veterans. The Written Informed Consent Act would direct the Secretary of Veterans Affairs to update Veterans Health Administration Directive 1005 (May 13, 2020), "Informed Consent for Long-Term Opioid Therapy for Pain", so the directive's informed consent framework also covers antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics used in VA care and the change does not create new funding, eligibility, or enforcement provisions.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
More informed consent for VA medications
This bill would require the Secretary of Veterans Affairs to update VHA Directive 1005 (dated May 13, 2020, "Informed Consent for Long-Term Opioid Therapy for Pain"). The update would make that informed-consent framework apply to antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics in VA clinical care. If enacted, VA clinicians who prescribe or manage those medicine classes would follow the expanded consent steps and veterans would receive the added disclosures. The provision does not create new funding, change eligibility, or set an effective date in the text provided.
Sponsors & CoSponsors
Sponsor
Sheehy, Tim [R-MT]
MT • R
Cosponsors
Sen. Tuberville, Tommy [R-AL]
AL • R
Sponsored 12/2/2025
Sen. Daines, Steve [R-MT]
MT • R
Sponsored 3/5/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov